Humans produce new neurons affecting learning, memory and emotion throughout our lives

brain neuron

Humans continue to produce new neurons in a part of their brain involved in learning, memory and emotion throughout adulthood, scientists have revealed, countering previous theories that production stopped after adolescence. The findings could help in developing treatments for neurological conditions such as dementia.

[Maura] Boldrini and colleagues looked at the hippocampus in 28 men and women aged between 14 and 79, collected just hours after they had died.

Using a number of techniques, the team examined the degree of new blood vessel formation, the volume, and the number of cells of different stages of maturity, in an area known as the dentate gyrus.

The team found levels of these “mother cells” dropped with age in the front and middle region of the dentate gyrus. However, levels of the cells they give rise to did not drop, with the team finding thousands of new, immature neurons in the dentate gyrus at the time of death regardless of age.

[T]here was a drop in the front of the dentate gyrus in the number of cells producing substances linked to neuroplasticity – the ability for the brain to change or “rewire”.

The authors note that a drop in plasticity might help explain why even healthy people can become more emotionally vulnerable as they age, but that the formation of new cells including neurons might help protect against cognitive or emotional decline.

Read full, original post: Humans produce new brain cells throughout their lives, say researchers

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Screenshot-2026-05-01-at-1.29.41-PM
Viewpoint: What happens when whole grains meet modern food manufacturing? Labels don’t tell the whole story.
S
As vaccine rejectionism spreads, measles may be taking a more dangerous turn
ChatGPT-Image-Apr-13-2026-02_20_22-PM
Viewpoint: Misinformation infodemic? Why assessing evidence is so challenging 
Screenshot-2026-04-20-at-2.26.27-PM
Viewpoint — Food-fear world: The latest activist scientists campaign: Cancer-causing additives
ChatGPT Image May 10, 2026, 08_16_59 PM 2
Overmedicalization? RFK Jr.’s antidepressant crackdown raises conflict questions over his fee stake in Wisner Baum, the tort firm built on suing drug makers
ChatGPT-Image-Mar-27-2026-11_47_30-AM-2
FDA’s expedited drug reviews are hailed in some quarters but other approval practices are problematic
Picture1-5
Science Disinformation Gap: The transatlantic battle over social media and censorship
Screenshot-2026-03-13-at-12.14.04-PM
The FDA wants to make many popular prescription drugs OTC—a great idea. Here’s why it’s unlikely to happen
bigstock opioids on chalkboard with rol
GLP podcast: 'Safe injection sites': enabling drug addiction or saving lives?
circular-bioeconomy-should-focus-on-sustainable-wellbeing
GLP podcast: What's wrong with 'doomsday' environmentalism? It's false.
Screenshot-2026-04-12-135256
Bixonimania: The fake disease scam that AI swallowed whole
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.